Hepatitis B reactivation in patients treated with direct-acting antivirals for Hepatitis C
Conclusion:Patients with HBV/HCV co-infection have a high risk of HBVr after DAA treatment and should receive antiviral prophylaxis. Patients with resolved infection have a low risk of HBVr and can be monitored by serial ALT measurements.
Source: Digestive Diseases - Category: Gastroenterology Source Type: research
More News: Databases & Libraries | Gastroenterology | Hepatitis | Hepatitis B | Hepatitis C | Liver | Liver Transplant | Study | Transplants | Urology & Nephrology | Viread